Introducing perfusion bioreactors to the bioprocessing industry marks the single greatest shift in technology for more productive and continuous cell cultures. These systems enable the growth of cells within controlled spaces and supply the elements for the prompt removal of byproducts and for the addition of growth medium. When biopharmaceutical companies invest in perfusion bioreactor technology, they will notice a significant boost in yield with a consequent drop in time required to produce and market vital therapies and products. Our offers are designed for the individual needs of a range of clients across the world of biotechnology.
Copyright © 2026 by Shanghai Ritai Medicine Equipment Project Co., Ltd. - Privacy policy